ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis

Immune checkpoint inhibitors (ICIs) are increasingly being used to manage multiple tumor types. Unfortunately, immune-related adverse events affect up to 60% of recipients, often leading to treatment discontinuation in settings where few alternative cancer therapies may be available. Checkpoint inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mann, Jacqueline E, Lucca, Liliana, Austin, Matthew R, Merkin, Ross D, Robert, Marie E, Al Bawardy, Badr, Raddassi, Khadir, Aizenbud, Lilach, Joshi, Nikhil S, Hafler, David A, Abraham, Clara, Herold, Kevan C, Kluger, Harriet M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432652/
https://www.ncbi.nlm.nih.gov/pubmed/37586769
http://dx.doi.org/10.1136/jitc-2023-007358

Ejemplares similares

Ejemplares similares